1992 Illustrated Weekly Aashi Pharmachem

1992 Illustrated Weekly Aashi Pharmachem

In collections

Metadata (MODS)
Titles 1992 Illustrated Weekly Aashi Pharmachem
Related Item Illustrated Weekly
Genre medicine
Genre medicines (other)
Identifier DSC_0691.JPG
Note AASHI PHARMACHEM LTD IS GEARED UP TO ANNOUNCE ITS PRESENCE IN THE WORLD DRUG MARKET 100% EOU HIGHLIGHTS 100% Export Oriented Unit. Entitlement of 60% of Foreign exchange is convertible in Indian Rupees at Market rate. Marketing tie-ups made for Purchase of full Production for 5 years. Tax concessions under 80 HHC, 80 M under Income Tax and Wealth Tax benefits. Relief in sales tax, excise & customs duty. Low gestation period. Commercial production expected in September '92. Technical know-how provided by well established consultants. Notified backward area under Category II, eligible for cash subsidy. Manufacturing and Export of life-saving drugs Atenolol, Propranolol HCL & Nifedipine etc. Land already acquired. Construction of Factory complex and office buildings in full swing. Risks as perceived by the Management While assessing the cost of Project, adequate provision has been made for contingencies. However, the capital cost of the assets are subject to fluctuations due to price rise in input costs. This may lead to overrun in the project cost. Some of the Raw materials required for the project are to be imported. The cost of such raw materials is subject to fluctuations depending on the changes in the Government policies from time to time and is also subject to International Price fluctuations. However, the unit being an 100% EOU the Company does not envisage any problem for procuring imported raw materials. Product life-cycle may be affected with introduction of new generation drugs. Turnover, Profitability projections are dependent on achieving USP/BP quality and guaranteed yield. Convertible Foreign Exchange into Indian Rupees is subject to any change in Government policy time to time. Benefits under 100% EOU scheme are subject to changes in the Government Policies. The Company has received the sanction in principle of the Gujarat Electricity Board for supply of power. However, the Company has also made arrangements to install Diesel Generating Sets to ensure continuous supply of power. The Company is yet to receive the clearance from the Gujarat Pollution Control Board. However, the Company has already provided for an Effluent Treatment Plant in the cost of the project. Land already acquired. Construction of Factory complex and office buildings in full swing. Though the Company is yet to place the orders for the Plant and Machinery, it is expected that the plant and machinery would be delivered and installed by June 1992. Public Issue of 39,00,000 Equity Shares of Rs. 10 each for cash at par aggregating Rs. 390 Lacs ISSUE OPENS ON: 7TH APRIL, 1992 ISSUE CLOSES ON: 17TH APRIL, 1992 EARLIEST CLOSING: 10TH APRIL, 1992 17% Secured Non Convertible Debentures for Rs. 250 Lacs, forming the part of the project cost have only been privately tied up by the promoters of the Company and an amount of Rs. 64 Lacs has been brought into the Company at the time of filing of Prospectus. The balance amount of Rs. 186 lacs is proposed to be brought in by the promoters within two months from the date of public issue. While the Company has a firm commitment for lease finance, which forms the part of the project cost, the Company is yet to avail of the same. LEAD MANAGERS TO THE ISSUE Gujarat Lease Financing Limited Merchant Banking Division Hasubhai Chambers, Opp. Town Hall Ellisbridge, Ahmedabad 380 006. State Bank of Indore Karim Chambers. 44, Ambalal Doshi Marg. Fort, Bombay 400 023. If the Company does not receive minimum subscription of 90% of the issue amount, the entire subscription will be refunded to the applicants within 90 days from the closure to this issue. If there is a delay in refund of such amount by more than 10 days, the Company will pay interest @ 15% P.A. for the delayed period. AASHI PHARMACHEM LTD. Factory & Regd. Office: Nalsarovar Road, Tal. - Dholka, Dist. Ahmedabad. Tel : 26987. Fax No.: 91-272-24566. AASHI
Abstract This is an ad for Aashi Pharmachem Ltd. The ad announces the presence of Aashi Pharmachem in the world drug market. The ad states that the company manufactures and exports life-saving drugs Atenolol, Propranolol HCL and Nifedipine. The ad contains an image of the Aashi logo.